{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:14:40Z","timestamp":1769926480608,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017932","name":"Western University of Health Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017932","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Canine atopic dermatitis (CAD) is a common genetically predisposed, inflammatory, and pruritic skin disorder that affects dogs globally. To date, there are no specific biomarkers available to diagnose CAD, and the current diagnosis is based on a combination of criteria including patient history, clinical signs, and exclusion of other relevant differential diagnoses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and results<\/jats:title>\n            <jats:p>We examined the gene expression of phosphodiesterase 4D (PDE4D) in peripheral blood mononuclear cells (PBMCs), as well as miR-203 and miR-483 in plasma, in three groups: healthy dogs, CAD dogs, and other inflammatory pruritic skin diseases (OIPSD) such as pemphigus foliaceus, scabies, cutaneous lymphoma, and dermatophytosis. Our results showed that PDE4D gene expression in the CAD group is statistically higher compared to those in the healthy and OIPSD groups, suggesting PDE4D may be a specific marker for CAD. Nevertheless, no correlation was found between PDE4D gene expression levels and the lesion severity gauged by CAD severity index-4 (CADESI-4). We also showed that miR-203 is a generic marker for clinical dermatitis and differentiates both CAD and OIPSD inflammatory conditions from healthy controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We show that PDE4D is a potential marker to differentiate CAD from non-atopic healthy and OIPSD while miR-203 may be a potential marker for general dermatologic inflammation. Future study of PDE4D and miR-203 on a larger scale is warranted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11033-024-09605-3","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T16:01:36Z","timestamp":1715443296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PDE4D and miR-203 are promising biomarkers for canine atopic dermatitis"],"prefix":"10.1007","volume":"51","author":[{"given":"Gagandeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Najera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jijun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"issue":"11","key":"9605_CR1","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2460\/javma.254.11.1291","volume":"254","author":"TJ Nuttall","year":"2019","unstructured":"Nuttall TJ et al (2019) Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs. J Am Vet Med Assoc 254(11):1291\u20131300","journal-title":"J Am Vet Med Assoc"},{"issue":"3\u20134","key":"9605_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0165-2427(01)00312-9","volume":"81","author":"DJ DeBoer","year":"2001","unstructured":"DeBoer DJ, Hillier A (2001) The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Vet Immunol Immunopathol 81(3\u20134):271\u2013276","journal-title":"Vet Immunol Immunopathol"},{"issue":"5","key":"9605_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/vde.12782","volume":"30","author":"ND Harvey","year":"2019","unstructured":"Harvey ND et al (2019) Environmental risk factors for canine atopic dermatitis: a retrospective large-scale study in Labrador and golden retrievers. Vet Dermatol 30(5):396\u2013e119","journal-title":"Vet Dermatol"},{"issue":"4","key":"9605_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11882-014-0423-y","volume":"14","author":"A Rabenhorst","year":"2014","unstructured":"Rabenhorst A, Hartmann K (2014) Interleukin-31: a novel diagnostic marker of allergic diseases. Curr Allergy Asthma Rep 14(4):423","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"9605_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1365-3164.2012.01098.x","volume":"24","author":"AJ Gonzales","year":"2013","unstructured":"Gonzales AJ et al (2013) Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 24(1):48\u201353e11","journal-title":"Vet Dermatol"},{"issue":"6","key":"9605_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/vde.12894","volume":"31","author":"R Asahina","year":"2020","unstructured":"Asahina R et al (2020) Serum canine thymus and activation-regulated chemokine (TARC\/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis. Vet Dermatol 31(6):446\u2013455","journal-title":"Vet Dermatol"},{"issue":"6","key":"9605_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/vde.12965","volume":"32","author":"R Marsella","year":"2021","unstructured":"Marsella R (2021) Advances in our understanding of canine atopic dermatitis. Vet Dermatol 32(6):547\u2013e151","journal-title":"Vet Dermatol"},{"issue":"6","key":"9605_CR8","doi-asserted-by":"publisher","first-page":"e0218670","DOI":"10.1371\/journal.pone.0218670","volume":"14","author":"J Koury","year":"2019","unstructured":"Koury J et al (2019) Phosphodiesterase 4D, miR-203 and selected cytokines in the peripheral blood are associated with canine atopic dermatitis. PLoS ONE 14(6):e0218670","journal-title":"PLoS ONE"},{"issue":"28","key":"9605_CR9","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.2174\/0929867324666170530093902","volume":"24","author":"LI Sakkas","year":"2017","unstructured":"Sakkas LI, Mavropoulos A, Bogdanos DP (2017) Phosphodiesterase 4 inhibitors in Immune-mediated diseases: Mode of Action, clinical applications, current and future perspectives. Curr Med Chem 24(28):3054\u20133067","journal-title":"Curr Med Chem"},{"issue":"4","key":"9605_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.trsl.2011.01.007","volume":"157","author":"R Dai","year":"2011","unstructured":"Dai R, Ahmed SA (2011) MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 157(4):163\u2013179","journal-title":"Transl Res"},{"issue":"1","key":"9605_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12917-015-0515-5","volume":"11","author":"P Hensel","year":"2015","unstructured":"Hensel P et al (2015) Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification. BMC Vet Res 11(1):196","journal-title":"BMC Vet Res"},{"issue":"2","key":"9605_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/vde.12107","volume":"25","author":"T Olivry","year":"2014","unstructured":"Olivry T et al (2014) Validation of the Canine atopic dermatitis extent and severity index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs. Vet Dermatol 25(2):77\u201385e25","journal-title":"Vet Dermatol"},{"issue":"2","key":"9605_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1365-3164.2004.00362.x","volume":"15","author":"CF Curtis","year":"2004","unstructured":"Curtis CF (2004) Current trends in the treatment of Sarcoptes, Cheyletiella and Otodectes mite infestations in dogs and cats. Vet Dermatol 15(2):108\u2013114","journal-title":"Vet Dermatol"},{"issue":"3","key":"9605_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1365-3164.2009.00793.x","volume":"21","author":"J Fontaine","year":"2010","unstructured":"Fontaine J, Heimann M, Day MJ (2010) Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases. Vet Dermatol 21(3):267\u2013275","journal-title":"Vet Dermatol"},{"issue":"3","key":"9605_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/vde.12440","volume":"28","author":"KA Moriello","year":"2017","unstructured":"Moriello KA et al (2017) Diagnosis and treatment of dermatophytosis in dogs and cats.: clinical Consensus guidelines of the World Association for Veterinary Dermatology. Vet Dermatol 28(3):266\u2013e68","journal-title":"Vet Dermatol"},{"issue":"2","key":"9605_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-3164.2004.00360.x","volume":"15","author":"WS Rosenkrantz","year":"2004","unstructured":"Rosenkrantz WS (2004) Pemphigus: current therapy. Vet Dermatol 15(2):90\u201398","journal-title":"Vet Dermatol"},{"issue":"2","key":"9605_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/vde.12197","volume":"26","author":"D Santoro","year":"2015","unstructured":"Santoro D et al (2015) Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction. Vet Dermatol 26(2):84\u2013e25","journal-title":"Vet Dermatol"},{"issue":"1","key":"9605_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-3164.2009.00758.x","volume":"21","author":"C Favrot","year":"2010","unstructured":"Favrot C et al (2010) A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 21(1):23\u201331","journal-title":"Vet Dermatol"},{"key":"9605_CR19","doi-asserted-by":"crossref","unstructured":"Schick MA, Schlegel N (2022) Clinical implication of Phosphodiesterase-4-Inhibition. Int J Mol Sci, 23(3)","DOI":"10.3390\/ijms23031209"},{"issue":"1","key":"9605_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/exd.13808","volume":"28","author":"E Guttman-Yassky","year":"2019","unstructured":"Guttman-Yassky E et al (2019) The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition. Exp Dermatol 28(1):3\u201310","journal-title":"Exp Dermatol"},{"issue":"8","key":"9605_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/1346-8138.13231","volume":"43","author":"O Nemoto","year":"2016","unstructured":"Nemoto O et al (2016) Effect of topical phosphodiesterase 4 inhibitor E6005 on Japanese children with atopic dermatitis: results from a randomized, vehicle-controlled exploratory trial. J Dermatol 43(8):881\u2013887","journal-title":"J Dermatol"},{"issue":"3","key":"9605_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","volume":"75","author":"AS Paller","year":"2016","unstructured":"Paller AS et al (2016) Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol 75(3):494\u2013503e6","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"9605_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/vr.145.7.191","volume":"145","author":"L Ferrer","year":"1999","unstructured":"Ferrer L et al (1999) Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis. Vet Rec 145(7):191\u2013194","journal-title":"Vet Rec"},{"issue":"5","key":"9605_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jamadermatol.2019.0008","volume":"155","author":"H Yang","year":"2019","unstructured":"Yang H et al (2019) Application of Topical Phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis: a systematic review and Meta-analysis. JAMA Dermatol 155(5):585\u2013593","journal-title":"JAMA Dermatol"},{"issue":"7","key":"9605_CR25","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1371\/journal.pone.0000610","volume":"2","author":"E Sonkoly","year":"2007","unstructured":"Sonkoly E et al (2007) MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE 2(7):e610","journal-title":"PLoS ONE"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09605-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T03:11:42Z","timestamp":1738725102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09605-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9605"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09605-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"24 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee (IACUC) of Western University of Health Sciences (Pomona, CA, USA). All the enrolled dogs were client owned patients at the Pet Health Center at the Western University of Health Sciences and the Animal Dermatology Clinic (Pasadena, CA, USA), and an informed owner consent form was obtained for each enrolled dog.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial interests"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"651"}}